Wees, I. R., Ayers, C., Ruberg, F. L., Maurer, M. S., Brailovsky, Y., Stern, L. K., … Grodin, J. L. (2026). Clinical Implications of the P.V142I TTR Variant: Insights From CARS. JACC Heart Fail, 14(2), 102704. https://doi.org/10.1016/j.jchf.2025.102704

Wees, Isabel R., Colby Ayers, Frederick L. Ruberg, Mathew S. Maurer, Yevgeniy Brailovsky, Lily K. Stern, Jan M. Griffin, Michel G. Khouri, Lori R. Roth, and Justin L. Grodin. “Clinical Implications of the P.V142I TTR Variant: Insights From CARS.” JACC Heart Fail 14, no. 2 (February 2026): 102704. https://doi.org/10.1016/j.jchf.2025.102704.

Wees IR, Ayers C, Ruberg FL, Maurer MS, Brailovsky Y, Stern LK, et al. Clinical Implications of the P.V142I TTR Variant: Insights From CARS. JACC Heart Fail. 2026 Feb;14(2):102704.

Wees, Isabel R., et al. “Clinical Implications of the P.V142I TTR Variant: Insights From CARS.” JACC Heart Fail, vol. 14, no. 2, Feb. 2026, p. 102704. Pubmed, doi:10.1016/j.jchf.2025.102704.

Wees IR, Ayers C, Ruberg FL, Maurer MS, Brailovsky Y, Stern LK, Griffin JM, Khouri MG, Roth LR, Grodin JL. Clinical Implications of the P.V142I TTR Variant: Insights From CARS. JACC Heart Fail. 2026 Feb;14(2):102704.